- Home
- CXE vs ME Comparison
CXE vs ME Comparison
Compare CXE & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXE
- ME
- Stock Information
- Founded
- CXE 1989
- ME 2006
- Country
- CXE United States
- ME United States
- Employees
- CXE N/A
- ME N/A
- Industry
- CXE Investment Managers
- ME Precision Instruments
- Sector
- CXE Finance
- ME Health Care
- Exchange
- CXE Nasdaq
- ME Nasdaq
- Market Cap
- CXE 115.4M
- ME 98.7M
- IPO Year
- CXE N/A
- ME N/A
- Fundamental
- Price
- CXE $3.70
- ME $3.54
- Analyst Decision
- CXE
- ME Hold
- Analyst Count
- CXE 0
- ME 1
- Target Price
- CXE N/A
- ME $9.40
- AVG Volume (30 Days)
- CXE 62.9K
- ME 226.1K
- Earning Date
- CXE 01-01-0001
- ME 02-05-2025
- Dividend Yield
- CXE 4.36%
- ME N/A
- EPS Growth
- CXE N/A
- ME N/A
- EPS
- CXE 0.07
- ME N/A
- Revenue
- CXE N/A
- ME $193,260,000.00
- Revenue This Year
- CXE N/A
- ME $21.93
- Revenue Next Year
- CXE N/A
- ME $17.31
- P/E Ratio
- CXE $51.00
- ME N/A
- Revenue Growth
- CXE N/A
- ME N/A
- 52 Week Low
- CXE $2.95
- ME $2.66
- 52 Week High
- CXE $3.67
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- CXE 49.66
- ME 48.48
- Support Level
- CXE $3.62
- ME $3.34
- Resistance Level
- CXE $3.78
- ME $3.95
- Average True Range (ATR)
- CXE 0.04
- ME 0.29
- MACD
- CXE 0.01
- ME 0.01
- Stochastic Oscillator
- CXE 61.11
- ME 37.87
About CXE MFS High Income Municipal Trust
Mfs High Income Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.